Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study

References

• Trinchieri AA. Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab. 2008;5:101–106.
   PubMedGoogle Scholar
• Yasui T, Iguchi M, Suzuki S, et al. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urol. 2008;71:209–213.
   PubMed Web of Science ®Google Scholar
• Hosseini MM, Shakeri S, Manaheji F, et al. Stone composition in patients who undergo renal stone surgery: review of 423 stone analyses in Southern Iran. Iran J Med Sci. 2014;39:75–76.
   PubMedGoogle Scholar
• Butterweck V, Khan SR. Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med. 2009;75:1095–1103.
   PubMed Web of Science ®Google Scholar
• Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598–2608.
   PubMed Web of Science ®Google Scholar
• Tiselius HG. Epidemiology and medical management of stone disease. BJU Int. 2003;91:758–767.
   PubMed Web of Science ®Google Scholar
• Finlayson B, Reid S. The expectation of free and fixed particles in urinary stone disease. Invest Urol. 1978;15:442–448.
   PubMedGoogle Scholar
• Masao T. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol. 2008;15:115–120.
   PubMed Web of Science ®Google Scholar
• Prasad K, Sujatha D, Bharathi K. Herbal drugs in urolithiasis - a review. Phcog Rev. 2007;1:175–179.
   Google Scholar
• Doddametikurke RB, Biyani CS, Browning AJ, et al. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium-containing renal stones. EAU-EBU Update Series. 2007;5:126–136.
   Google Scholar
• Atmani F, Slimani Y, Mimouni M, et al. Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. British J Urol Int. 2003;92:137–140.
   Google Scholar
• Schütz K, Carle R, Schieber A. Taraxacum are view on its phytochemical and pharmacological profile. J Ethnopharmacol. 2006;107:313–323.
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Kang HJ, Jung HJ, et al. Anti-inflammatory activity of Taraxacum officinale. J Ethnopharmacol. 2008;115:82–88.
   PubMed Web of Science ®Google Scholar
• Yassen G, Ahmad M, Sultana S, et al. Ethnobotany of medicinal plants in the Thar Desert (Sindh) of Pakistan. J Ethnopharmacol. 2015;163:43–59.
   PubMed Web of Science ®Google Scholar
• Wright CI, Van-Buren L, Kroner CI, et al. Herbal medicines as diuretics: a review of the scientific evidence. J Ethnopharmacol. 2007;114:1–31.
   PubMed Web of Science ®Google Scholar
• Sharma K, Zafar R. Optimization of methyl jasmonate and β-cyclodextrin for enhanced production of taraxerol and taraxasterol in (Taraxacum officinale Weber) cultures. Plant Physiol Biochem. 2016;103:24–30.
   PubMed Web of Science ®Google Scholar
• Song Y, Hernandez N, Shoag J, et al. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis. Urolithiasis. 2016;44:145–148.
   PubMed Web of Science ®Google Scholar
• Eidi A, Zarringhalam Moghadam J, Mortazavi P, et al. Hepatoprotective effects of Juglans regia extract against CCl4-induced oxidative damage in rats. Pharmaceut Biol. 2013;51:558–565.
   PubMed Web of Science ®Google Scholar
• Burns JR, Finlayson B. A proposal for standard reference artificial urine in in vitro urolithiasis experiments. J Urol. 1980;18:167–169.
   Google Scholar
• Hennequin C, Lalanne V, Daudon M. A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res. 1993;21:101–108.
   PubMedGoogle Scholar
• Kok DJ, Papapolous SE, Bijovet OL. Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int. 1990;37:51–56.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Tsugawa R. Analysis of glycosaminoglycans included in newly-formed calcium oxalate crystals using an undiluted urine system. Scan Microsc. 1995;9:1089–1096.
   PubMedGoogle Scholar
• Pak CYC, Resnick MI. Medical therapy and new approaches to management of urolithiasis. Urol Clin North Am. 2000;27:243–253.
   PubMed Web of Science ®Google Scholar
• Nagal A, Singla RK. Herbal resources with anti-urolithiatic effects: a review. Indo Glob J Pharm Sci. 2013;3:6–14.
   Google Scholar
• Choudhary A, Singla SK, Tandon C. In vitro evaluation of Terminalia arjuna on calcium phosphate and calcium oxalate crystallization. Indian J Pharmceut Sci. 2010;72:340–345.
   PubMed Web of Science ®Google Scholar
• Saha S, Verma RJ. Evaluation of hydro-alcoholic extract of Dolichos biflorus seeds on inhibition of calcium oxalate crystallization. J Herbal Med. 2015;5:41–47.
   Web of Science ®Google Scholar
• Barros ME, Schor N, Boim MA. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res. 2003;30:374–379.
   PubMedGoogle Scholar
• Saranya R, Geetha N. Inhibition of calcium oxalate (CaOx) crystallization in vitro by the extract of beet root (Beta vulgaris L.). Int J Pharm Pharmaceut Sci. 2014;6:361–365.
   Google Scholar
• Aggarwal D, Kaushal R, Kaur T, et al. The most potent antilithiatic agent ameliorating renal dysfunction and oxidative stress from Bergenia ligulata rhizome. J Ethnopharmacol. 2014;158:85–93.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Tandon S, Singla KS, et al. Diminution of oxalate Induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris. Int Braz j Urol. 2010;36:480–489.
   PubMed Web of Science ®Google Scholar
• Wesson JA, Worcester EM, Wiessner JH, et al. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int. 1998;53:952–957.
   PubMed Web of Science ®Google Scholar
• Jethi RK, Duggal B, Sahota RS, et al. Effect of the aqueous extract of an ayurvedic compound preparation on mineralization and demineralization reaction. Indian J Med Res. 1983;78:422–425.
   PubMed Web of Science ®Google Scholar
• Patra KC, Harwansh H. In vitro calcium oxalate crystallization inhibition by Achyranthes indica Linn. Hydroalcoholic extract: an approach to antilithiasis. Int J Pharm Biol Sci. 2011;2:432–437.
   Google Scholar
• Morales P, Ferreira ICFR, Carvalho AM, et al. Mediterranean non-cultivated vegetable as dietary sources of compounds with antioxidant and biological activity. LWT Food Sci Technol. 2014;55:389–396.
   Web of Science ®Google Scholar
• Kalny P, Fijałek Z, Daszczuk A, et al. Determination of selected microelements in Polish herbs and their infusions. Sci Total Environ. 2007;381:99–104.
   PubMed Web of Science ®Google Scholar
• Zhong YS, Yu CH, Ying HZ, et al. Prophylactic effects of Orthosiphon stamineus Benth. Extract on experimental induction of calcium oxalate nephrolithiasis in rats. J Ethnopharmacol. 2012;144:761–767.
   PubMed Web of Science ®Google Scholar
• Noorafshan A, Doust SK, Karimi F. Diosmin reduces calcium oxalate deposition and tissue degeneration in nephrolithiasis in rats: a stereological study. Korean J Urol. 2013;54:252–257.
   PubMedGoogle Scholar
• Gurocak S, Kupeli B. Consumption of historical and current phyto-therapeutic agents for urolithiasis: a critical review. J Urol. 2006;176:450–455.
   PubMed Web of Science ®Google Scholar